Robert A. Hromas

Dr. Hromas is an international authority in blood cancers and a leader in translational research and drug discovery in cancer therapies. He has published more than 150 research articles, has two patents, and three patents pending, for novel cancer therapies. He has access to many renowned investigators with novel targets, which helps to advance Cloud Pharmaceuticals’ research and development efforts. He currently holds more than $3.5 million in grants, and his research has been continuously funded since 1992 by the National Institutes of Health, with additional funding from the Leukemia and Lymphoma Society. He has been elected a Fellow of the American College of Physicians, a member of the American Society of Clinical Investigation, and a member of the Association of American Physicians.